Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0241726
Disease: Delayed ability to walk
Delayed ability to walk 		0.100 Biomarker phenotype HPO
CUI: C0332615
Disease: Myopathic facies
Myopathic facies 		0.100 Biomarker phenotype HPO
CUI: C0423109
Disease: Upward slant of palpebral fissure
Upward slant of palpebral fissure 		0.100 Biomarker phenotype HPO
CUI: C0423112
Disease: Short palpebral fissure
Short palpebral fissure 		0.100 Biomarker phenotype HPO
CUI: C0426415
Disease: Large nose
Large nose 		0.100 Biomarker phenotype HPO
CUI: C0426970
Disease: Spastic Quadriplegia
Spastic Quadriplegia 		0.100 Biomarker disease HPO
CUI: C0431478
Disease: Posteriorly rotated ear
Posteriorly rotated ear 		0.100 Biomarker disease HPO
CUI: C0454644
Disease: Delayed speech and language development
Delayed speech and language development 		0.100 Biomarker phenotype HPO
CUI: C0557874
Disease: Global developmental delay
Global developmental delay 		0.100 Biomarker disease HPO
CUI: C0678230
Disease: Congenital Epicanthus
Congenital Epicanthus 		0.100 Biomarker disease HPO
CUI: C1306503
Disease: Congenital exomphalos
Congenital exomphalos 		0.100 Biomarker disease HPO
CUI: C1854882
Disease: Absent speech
Absent speech 		0.100 Biomarker phenotype HPO
CUI: C1858120
Disease: Generalized hypotonia
Generalized hypotonia 		0.100 Biomarker phenotype HPO
CUI: C1861324
Disease: Short philtrum
Short philtrum 		0.100 Biomarker phenotype HPO
CUI: C1865014
Disease: Long philtrum
Long philtrum 		0.100 Biomarker phenotype HPO
CUI: C1865017
Disease: Thin upper lip vermilion
Thin upper lip vermilion 		0.100 Biomarker phenotype HPO
CUI: C4082304
Disease: Oligodontia
Oligodontia 		0.100 Biomarker disease HPO
CUI: C4281771
Disease: Thin eyebrow
Thin eyebrow 		0.100 Biomarker phenotype HPO
CUI: C4553743
Disease: Spasticity, CTCAE
Spasticity, CTCAE 		0.100 Biomarker phenotype HPO
CUI: C0027651
Disease: Neoplasms
Neoplasms 		0.100 Biomarker group BEFREE <b>Results:</b> While the population of LY6C<sup>hi</sup> monocytes was increased in non-treated tumor-bearing mice, the treatment with ATL-1 diminished the population of LY6C<sup>hi</sup> monocytes in spleen, blood and bone marrow, decreasing macrophage infiltration into the tumor and reducing the M2 markers expression on TAMs. 31275860 2019
CUI: C0023434
Disease: Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia 		0.080 GeneticVariation disease BEFREE B cell leukemia 11b (Bcl11b) is a zinc finger protein transcription factor with a multiplicity of functions. 28424591 2017
CUI: C2004493
Disease: Leukemia, B-Cell
Leukemia, B-Cell 		0.040 GeneticVariation disease BEFREE B cell leukemia 11b (Bcl11b) is a zinc finger protein transcription factor with a multiplicity of functions. 28424591 2017
CUI: C0023434
Disease: Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia 		0.080 Biomarker disease BEFREE B-cell chronic lymphocytic leukemia/lymphoma 11B (BCL11B) plays a key role in the development, proliferation, differentiation, and survival of T cells. 28794504 2017
CUI: C1868683
Disease: B-CELL MALIGNANCY, LOW-GRADE
B-CELL MALIGNANCY, LOW-GRADE 		0.020 Biomarker disease BEFREE B-cell chronic lymphocytic leukemia/lymphoma 11B (BCL11B) plays a key role in the development, proliferation, differentiation, and survival of T cells. 28794504 2017
CUI: C0023418
Disease: leukemia
leukemia 		0.010 Biomarker disease BEFREE BCL11B is a homolog to BCL11A (2p13), a highly conserved gene implicated in mouse and human leukemias. 15104287 2004